A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line

Biochemical and Biophysical Research Communications

Volumn 321, Issue 4, 2004, Pages 1010-1016

  Gao, Chengjiang ^a   Mi, Zhiyong ^a   Guo, Hongtao ^a   Wei, Junping ^a   Wai, Philip Y ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; hnRNP A B; Metastasis; Osteopontin

Indexed keywords

OSTEOPONTIN; TIOGUANINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL LINE; CELL MOTILITY; CORRELATION ANALYSIS; EPITHELIUM TUMOR; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OSTEOPONTIN; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; TRANSFECTION;

MURINAE;

EID: 3843068715     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.063     Document Type: Article

References (39)

1. D.R. Senger, C.A. Perruzzi, C.F. Gracey, A. Papadopoulos, and D.G. Tenen Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation Cancer Res. 48 1988 5770 5774
2. L.F. Brown, A. Papadopoulos-Sergiou, B. Berse, E.J. Manseau, K. Tognazzi, C.A. Perruzzi, H.F. Dvorak, and D.R. Senger Osteopontin expression and distribution in human carcinomas Am. J. Pathol. 145 1994 610 623
3. A. Bellahcene, and V. Castronovo Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer Am. J. Pathol. 146 1995 95 100
4. S. Hirota, A. Ito, J. Nagoshi, M. Takeda, A. Kurata, Y. Takatsuka, K. Kohri, S. Nomura, and Y. Kitamura Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci Lab. Invest. 72 1995 64 69
5. A.B. Tuck, F.P. O'Malley, H. Singhal, J.F. Harris, K.S. Tonkin, N. Kerkvliet, Z. Saad, G.S. Doig, and A.F. Chambers Osteopontin expression in a group of lymph node negative breast cancer patients Int. J. Cancer 79 1998 502 508
6. A.G. Casson, S.M. Wilson, J.A. McCart, F.P. O'Malley, H. Ozcelik, M.S. Tsao, and A.F. Chambers ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer Int. J. Cancer 72 1997 739 745
7. M. Gotoh, M. Sakamoto, K. Kanetaka, M. Chuuma, and S. Hirohashi Overexpression of osteopontin in hepatocellular carcinoma Pathol. Int. 52 2002 19 24
8. H. Singhal, D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival Clin. Cancer Res. 3 1997 605 611
9. C. Gao, H. Guo, J. Wei, Z. Mi, P. Wai, and P.C. Kuo S-Nitrosylation of hnRNP-A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages J. Biol. Chem. 279 2004 11236 11243
10. G.H. Heppner, F.R. Miller, and P.M. Shekhar Nontransgenic models of breast cancer Breast Cancer Res. 2 2000 331 334
11. C. Gao, H. Guo, L. Downey, C. Marroquin, J. Wei, and P.C. Kuo Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells Carcinogenesis 24 2003 1871 1878
12. A. Franzen, and D. Heinegard Isolation and characterization of two sialoproteins present only in bone calcified matrix Biochem. J. 232 1985 715 724
13. H. Chen, M. Hewison, B. Hu, and J.S. Adams Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance Proc. Natl. Acad. Sci. USA 100 2003 6109 6114
14. G. Dreyfuss, M. Hentze, and A.I. Lamond From transcript to protein Cell 85 1996 963 972
15. A.M. Krecic, and M.S. Swanson hnRNP complexes: composition, structure, and function Curr. Opin. Cell Biol. 11 1999 363 371
16. M. Tolnay, L.A. Vereshchagina, and G.C. Tsokos Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding protein Biochem. J. 338 1999 417 425
17. N. Tay, S.H. Chan, and E.C. Ren Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II J. Virol. 66 1992 6841 6848
18. T. Tomonaga, and D. Levens Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator J. Biol. Chem. 270 1995 4875 4881
19. D. Wang, and C.R. Parrish A heterogeneous nuclear ribonucleoprotein A/B-related protein binds to single-stranded DNA near the 5′ end or within the genome of feline parvovirus and can modify virus replication J. Virol. 73 1999 7761 7768
20. H. Chen, B. Hu, M.A. Gacad, and J.S. Adams Cloning and expression of a novel dominant-negative-acting estrogen response element-binding protein in the heterogeneous nuclear ribonucleoprotein family J. Biol. Chem. 273 1998 31352 31357
21. H. Chen, B. Hu, E.A. Allegretto, and J.S. Adams The vitamin D response element-binding protein. A novel dominant-negative regulator of vitamin D-directed transactivation J. Biol. Chem. 275 2000 35557 35564
22. B. Honore, U. Baandrup, and H. Vorum Heterogeneous nuclear ribonucleoproteins F and H/H′ show differential expression in normal and selected cancer tissues Exp. Cell Res. 294 2004 199 209
23. H. Satoh, H. Ishikawa, H. Kamma, Y.T. Yamashita, and K. Sekizawa HnRNP A2/B1 proteins in nontumorous alveolar cells Lung 181 2003 219 225
24. S. Wu, M. Sato, C. Endo, A. Sakurada, B. Dong, H. Aikawa, Y. Chen, Y. Okada, Y. Matsumura, E. Sueoka, and T. Kondo hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung Lung Cancer 41 2003 179 186
25. I. Pino, R. Pio, G. Toledo, N. Zabalegui, S. Vicent, N. Rey, M.D. Lozano, W. Torre, J. Garcia-Foncillas, and L.M. Montuenga Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer Lung Cancer 41 2003 131 143
26. J. Zhou, D.C. Allred, I. Avis, A. Martinez, M.D. Vos, L. Smith, A.M. Treston, and J.L. Mulshine Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer Breast Cancer Res. Treat. 66 2001 217 224
27. M.R. Pillai, P. Chacko, L.A. Kesari, P.G. Jayaprakash, H.N. Jayaram, and A.C. Antony Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer J. Clin. Pathol. 56 2003 569 574
28. N.S. Fedarko, A. Jain, A. Karadag, E.M. Van, and L.W. Fisher Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer Clin. Cancer Res. 7 2003 4060 4066
29. A.B. Tuck, F.P. O'Malley, H. Singhal, K.S. Tonkin, J.F. Harris, D. Bautista, and A.F. Chambers Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas Arch. Pathol. Lab. Med. 121 1997 578 584
30. A.B. Tuck, D.M. Arsenault, F.P. O'Malley, C. Hota, M.C. Ling, S.M. Wilson, and A.F. Chambers Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene 18 1999 4237 4246
31. T. Ue, H. Yokozaki, Y. Kitadai, S. Yamamoto, W. Yasui, T. Ishikawa, and E. Tahara Co-expression of osteopontin and CD44v9 in gastric cancer Int. J. Cancer 79 1998 127 132
32. N. Shijubo, T. Uede, S. Kon, M. Maeda, T. Segawa, A. Imada, M. Hirasawa, and S. Abe Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma Am. J. Respir. Crit Care Med. 160 1999 1269 1273
33. A.F. Chambers, S.M. Wilson, N. Kerkvliet, F.P. O'Malley, J.F. Harris, and A.G. Casson Osteopontin expression in lung cancer Lung Cancer 15 1996 311 323
34. G.N. Thalmann, R.A. Sikes, R.E. Devoll, J.A. Kiefer, R. Markwalder, I. Klima, C.M. Farach-Carson, U.E. Studer, and L.W. Chung Osteopontin: possible role in prostate cancer progression Clin. Cancer Res. 5 1999 2271 2277
35. H.W. Pan, Y.H. Ou, S.Y. Peng, S.H. Liu, P.L. Lai, P.H. Lee, J.C. Sheu, C.L. Chen, and H.C. Hsu Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer 98 2003 119 127
36. D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T.J. Yeatman Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J. Natl. Cancer Inst. 94 2002 513 521
37. A.B. Tuck, B.E. Elliott, C. Hota, E. Tremblay, and A.F. Chambers Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met) J. Cell Biochem. 78 2002 465 475
38. A.J. Oates, R. Barraclough, and P.S. Rudland The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model Oncogene 13 1996 97 104
39. H. Chen, Y. Ke, A.J. Oates, R. Barraclough, and P.S. Rudland Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line Oncogene 14 1997 1581 1588